Market Place
Sourcing Support
Eyes, Ears Get Their Due With Cell and Gene Therapy
03 Sep 2024 //
BIOSPACE
Lilly and Akouos Announce Expiration of Akouos Tender Offer
30 Nov 2022 //
PRNEWSWIRE
Akouos Reports 3Q 2022 Financial Results & Provides Business Highlights
14 Nov 2022 //
GLOBENEWSWIRE
String of gene therapy deals spurs cautious optimism on Wall Street
01 Nov 2022 //
BIOPHARMADIVE
Lilly Continues Foray into Gene Therapies with $487M Akouos Buyout
19 Oct 2022 //
BIOSPACE
Lilly to Acquire Akouos to Discover and Develop Treatments for Hearing Loss
18 Oct 2022 //
PRESS RELEASE
Akouos Receives FDA Clearance of its IND Application for AK-OTOF,
13 Sep 2022 //
GLOBENEWSWIRE
Akouos Reports Second Quarter 2022 Financial Results
15 Aug 2022 //
GLOBENEWSWIRE
Akouos Presents Nonclinical Data Supporting Development of AK-OTOF
19 May 2022 //
GLOBENEWSWIRE
Akouos Reports First Quarter 2022 Financial Results
12 May 2022 //
GLOBENEWSWIRE
Akouos to Present at Bank of America 2022 Healthcare Conference
04 May 2022 //
GLOBENEWSWIRE
Akouos to Present at the ASGCT 25th Annual Meeting
03 May 2022 //
GLOBENEWSWIRE
Akouos Reports Fourth Quarter and Full Year 2021 Financial Results
29 Mar 2022 //
GLOBENEWSWIRE
Akouos to Participate in Upcoming March Virtual Investor Conferences
24 Mar 2022 //
GLOBENEWSWIRE
Akouos Appoints Aaron Tward, M.D., Ph.D., as Chief Scientific Officer
10 Mar 2022 //
GLOBENEWSWIRE
Akouos to Present at Cowen 42nd Annual Heath Care Conference
01 Mar 2022 //
GLOBENEWSWIRE
Akouos Presents Nonclinical Data Showing Potential of Precision Genetic Medicine
07 Feb 2022 //
GLOBENEWSWIRE
Akouos to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference
22 Nov 2021 //
GLOBENEWSWIRE
Akouos Reports Q3 2021 Financial Results and Provides Business Highlights
12 Nov 2021 //
GLOBENEWSWIRE
EMA committee recommends orphan drug designation for Akouos’ AK-OTOF
11 Aug 2021 //
PHARMABIZ
Akouos Presents Nonclinical Data Supporting Future Clinical Develop of AK-OTOF
11 May 2021 //
GLOBENEWSWIRE
Akouos to Present Nonclinical Data from AK-OTOF and AK-antiVEGF Programs
27 Apr 2021 //
GLOBENEWSWIRE
Akouos Receives Orphan Drug and Rare Pediatric Disease Designations for AK-OTOF
13 Apr 2021 //
GLOBENEWSWIRE
Relay & iTeos join IPO deluge while Akouos and Fusion decide they
26 Jun 2020 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.